Erik Őrfi

493 total citations
9 papers, 393 citations indexed

About

Erik Őrfi is a scholar working on Immunology and Allergy, Genetics and Immunology. According to data from OpenAlex, Erik Őrfi has authored 9 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology and Allergy, 4 papers in Genetics and 4 papers in Immunology. Recurrent topics in Erik Őrfi's work include Food Allergy and Anaphylaxis Research (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Drug-Induced Adverse Reactions (3 papers). Erik Őrfi is often cited by papers focused on Food Allergy and Anaphylaxis Research (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Drug-Induced Adverse Reactions (3 papers). Erik Őrfi collaborates with scholars based in Hungary, United States and Netherlands. Erik Őrfi's co-authors include János Szebeni, László Dézsi, Tamás Fülöp, Rudolf Urbanics, László Rosivall, Tamás Mészáros, Gergely Tibor Kozma, Yechezkel Barenholz, Ildikó Vashegyi and Yaelle Bavli and has published in prestigious journals such as ACS Nano, Advanced Drug Delivery Reviews and The FASEB Journal.

In The Last Decade

Erik Őrfi

9 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Őrfi Hungary	7	147	144	94	84	57	9	393
Yaelle Bavli Israel	8	190 1.3×	137 1.0×	80 0.9×	67 0.8×	38 0.7×	11	383
Morgan D. McSweeney United States	12	170 1.2×	140 1.0×	71 0.8×	97 1.2×	98 1.7×	17	459
János Milosevits Hungary	6	129 0.9×	142 1.0×	113 1.2×	48 0.6×	31 0.5×	9	357
Aaron J. Sorrin United States	7	181 1.2×	116 0.8×	57 0.6×	152 1.8×	94 1.6×	9	456
Tian-Lu Cheng Taiwan	8	280 1.9×	238 1.7×	97 1.0×	156 1.9×	59 1.0×	10	602
Haroon Ahmad United States	8	154 1.0×	102 0.7×	36 0.4×	85 1.0×	43 0.8×	20	430
Scott Poh United States	11	115 0.8×	110 0.8×	62 0.7×	113 1.3×	36 0.6×	15	427
Hye‐Nam Son South Korea	12	152 1.0×	50 0.3×	46 0.5×	52 0.6×	46 0.8×	14	346
Qiyu Tang China	13	246 1.7×	123 0.9×	110 1.2×	103 1.2×	47 0.8×	44	644
Kelly A. Hartman United States	9	390 2.7×	287 2.0×	163 1.7×	318 3.8×	41 0.7×	9	741

Countries citing papers authored by Erik Őrfi

Since Specialization

Citations

This map shows the geographic impact of Erik Őrfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Őrfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Őrfi more than expected).

Fields of papers citing papers by Erik Őrfi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Őrfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Őrfi. The network helps show where Erik Őrfi may publish in the future.

Co-authorship network of co-authors of Erik Őrfi

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Őrfi. A scholar is included among the top collaborators of Erik Őrfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Őrfi. Erik Őrfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Őrfi, Erik, László Hricisák, László Dézsi, et al.. (2022). The Hypertensive Effect of Amphotericin B-Containing Liposomes (Abelcet) in Mice: Dissecting the Roles of C3a and C5a Anaphylatoxins, Macrophages and Thromboxane. Biomedicines. 10(7). 1764–1764. 1 indexed citations

Mészáros, Tamás, Erik Őrfi, Miklós Garami, et al.. (2021). Complement-mediated hypersensitivity reactions to an amphotericin B-containing lipid complex (Abelcet) in pediatric patients and anesthetized rats: Benefits of slow infusion. Nanomedicine Nanotechnology Biology and Medicine. 34. 102366–102366. 11 indexed citations

Őrfi, Erik, Tamás Mészáros, Mark Hennies, et al.. (2019). <p>Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice</p>. International Journal of Nanomedicine. Volume 14. 1563–1573. 20 indexed citations

Kozma, Gergely Tibor, Tamás Mészáros, Ildikó Vashegyi, et al.. (2019). Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions. ACS Nano. 13(8). 9315–9324. 155 indexed citations

Dézsi, László, Tamás Mészáros, Erik Őrfi, et al.. (2019). Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy. Molecules. 24(18). 3283–3283. 14 indexed citations

Őrfi, Erik, et al.. (2019). Anaphylatoxin C3a induces vasoconstriction and hypertension mediated by thromboxane A ₂ in mice. The FASEB Journal. 33(S1). 4 indexed citations

Unterweger, Harald, Christina Janko, Marc Schwarz, et al.. (2017). Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging. International Journal of Nanomedicine. Volume 12. 5223–5238. 84 indexed citations

Őrfi, Erik & János Szebeni. (2016). The immune system of the gut and potential adverse effects of oral nanocarriers on its function. Advanced Drug Delivery Reviews. 106(Pt B). 402–409. 21 indexed citations

Dézsi, László, Tamás Fülöp, Tamás Mészáros, et al.. (2014). Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses. Journal of Controlled Release. 195. 2–10. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact